L
Lawrence J Green, MD LLC | Rockville, MD
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
TAK-279
ABP 501
Ritlecitinib
Glycopyrronium
VP-315
Humira®
Sofpironium Bromide
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents with Nonsegmental Vitiligo (Active and Stable) Tranquillo
Enrolling
Stable Nonsegmental Vitiligo
Active Nonsegmental Vitiligo
Drug: Ritlecitinib
Drug: Placebo
The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque p...
Active, not recruiting
Plaque Psoriasis
Drug: TAK-279
Drug: Placebo
The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...
Enrolling
Plaque Psoriasis
Drug: TAK-279
Trial sponsors
B
J
V
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems